Skip to content

Expectant Management of Ectopic Pregnancy

Evaluation of Expectant Management in Women Diagnosed With a Tubal Ectopic Pregnancy at Ain-Shams University Maternity Hospital Over the Period From January 1, 2016 to December 31, 2020

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04975984
Enrollment
50
Registered
2021-07-26
Start date
2021-07-20
Completion date
2021-12-31
Last updated
2021-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ectopic Pregnancy

Brief summary

The aim of this study is to assess the efficacy and safety of expectant management in the treatment of tubal ectopic pregnancy and identification of different factors that can be used to predict its success.

Interventions

DIAGNOSTIC_TESTqualitative hCG levels and ultrasound criteria

detect upper limit of qualitative hCG levels associated with successful expectant management of ectopic pregnancy

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

\- all women who underwent expectant management as the first line of management offered after optimal counseling during the period from January 1, 2016 to December 31, 2020. 1. Hemodynamically stable with confirmed diagnosis of ectopic pregnancy on ultrasound scan. 2. No significant pelvic pain. 3. No hemoperitoneum. 4. No fetal heart in the ectopic pregnancy. 5. HCG level \<5000 IU/L. 6. Expectant management was the first line of management offered to the patient after optimal counseling.

Exclusion criteria

1. all women with non tubal ectopic pregnancy 2. all women with tubal ectopic pregnancy that recieved medical or surgical treatment as 1st line treatment

Design outcomes

Primary

MeasureTime frameDescription
resolution of hCG levelup to 12 weekshCG levels measured every week till negative less than (\<20 IU/l) up to 12 weeks

Countries

Egypt

Contacts

Primary ContactRadwa Rasheedy, MD
radwaebed@yahoo.com01283492979

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026